Wilson WH - Search Results

1

Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.

Janik JE, Morris JC, Pittaluga S, McDonald K, Raffeld M, Jaffe ES, Grant N, Gutierrez M, Waldmann TA, Wilson WH. Janik JE, et al. Among authors: wilson wh. Blood. 2004 Nov 15;104(10):3355-7. doi: 10.1182/blood-2003-11-3922. Epub 2004 Jun 17. Blood. 2004. PMID: 15205267 Free article.

2

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.

Wilson WH, Chabner BA, Bryant G, Bates S, Fojo A, Regis J, Jaffe ES, Steinberg SM, Goldspiel BR, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1995 Feb;13(2):381-6. doi: 10.1200/JCO.1995.13.2.381. J Clin Oncol. 1995. PMID: 7531220 Clinical Trial.

3

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy.

Wilson WH, Jamis-Dow C, Bryant G, Balis FM, Klecker RW, Bates SE, Chabner BA, Steinberg SM, Kohler DR, Wittes RE. Wilson WH, et al. J Clin Oncol. 1995 Aug;13(8):1985-94. doi: 10.1200/JCO.1995.13.8.1985. J Clin Oncol. 1995. PMID: 7636539 Clinical Trial.

4

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.

Wilson WH, Bates SE, Fojo A, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, et al. Wilson WH, et al. J Clin Oncol. 1995 Aug;13(8):1995-2004. doi: 10.1200/JCO.1995.13.8.1995. J Clin Oncol. 1995. PMID: 7636540 Clinical Trial.

5

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

Wilson WH, Bryant G, Bates S, Fojo A, Wittes RE, Steinberg SM, Kohler DR, Jaffe ES, Herdt J, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1993 Aug;11(8):1573-82. doi: 10.1200/JCO.1993.11.8.1573. J Clin Oncol. 1993. PMID: 7687667 Clinical Trial.

6

Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.

Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Wilson WH, et al. Blood. 1996 Jun 1;87(11):4531-7. Blood. 1996. PMID: 8639820 Free article.

7

Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas.

Wilson WH, Teruya-Feldstein J, Fest T, Harris C, Steinberg SM, Jaffe ES, Raffeld M. Wilson WH, et al. Blood. 1997 Jan 15;89(2):601-9. Blood. 1997. PMID: 9002964 Free article.

8

Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.

Zhan Z, Sandor VA, Gamelin E, Regis J, Dickstein B, Wilson W, Fojo AT, Bates SE. Zhan Z, et al. Blood. 1997 May 15;89(10):3795-800. Blood. 1997. PMID: 9160686 Free article.

9

The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease.

Teruya-Feldstein J, Jaffe ES, Burd PR, Kanegane H, Kingma DW, Wilson WH, Longo DL, Tosato G. Teruya-Feldstein J, et al. Among authors: wilson wh. Blood. 1997 Nov 15;90(10):4099-105. Blood. 1997. PMID: 9354680 Free article.

10

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.

Longo DL, Glatstein E, Duffey PL, Young RC, Ihde DC, Bastian AW, Wilson WH, Wittes RE, Jaffe ES, Hubbard SM, DeVita VT Jr. Longo DL, et al. Among authors: wilson wh. J Clin Oncol. 1997 Nov;15(11):3338-46. doi: 10.1200/JCO.1997.15.11.3338. J Clin Oncol. 1997. PMID: 9363863 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

548 results

Search Page

Filters